Viewing StudyNCT00003368



Ignite Creation Date: 2024-05-05 @ 11:07 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003368
Status: COMPLETED
Last Update Posted: 2013-03-21
First Post: 1999-11-01

Brief Title: Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: CDR0000066357
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Alliance for Clinical Trials in Oncology OTHER